Felbamate Suspension
Product Images NDC 70954-051

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Felbamate (NDC 70954-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novitium Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label1 (Felb 237)

Label1 (Felb 237)
Felbamate Oral Suspension USP 600 mg per 5 mL (120 mg per mL) label from Novitium Pharma LLC. It includes dosage strength, storage instructions (20° to 25°C with permitted excursions), and directions to shake well before use. The label also displays the NDC number 70954-051, manufacturer address, and a barcode.*
FDA Label Image

Label2 (Felb 473)

Label2 (Felb 473)
Label for Felbamate Oral Suspension, USP, containing 600 mg per 5 mL (120 mg per mL) of Felbamate. It is an oral suspension in a 473 mL container, labeled by Novitium Pharma LLC. The label includes storage instructions, dosage recommendations, and a barcode.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Felbamate, corresponding to the active ingredient in the Felbamate 600 mg/5mL oral suspension by Novitium Pharma LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.